RTW INVESTMENTS, LP Diversified Active

Location: New York, NY

CIK: 0001493215 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 21, 2015

Total Value: $222M (100.0% shares, 0.0% debt)

Holdings (24)

ALNY Alnylam Pharmaceuticals Inc 16.8%
Value $37.11M Shares 355,395 Est. Cost $93.01 Unrealized +8.9%
Dyax Corp 12.0%
Value $26.56M Shares 1,585,098 Est. Cost $14.06 Unrealized
Dicerna Pharmaceuticals Inc 10.8%
Value $23.81M Shares 990,981 Est. Cost $16.47 Unrealized
Kite Pharma Inc 9.8%
Value $21.67M Shares 375,623 Est. Cost $57.68 Unrealized
BCRX BioCryst Pharmaceuticals Inc 9.2%
Value $20.42M Shares 2,261,361 Est. Cost $11.05 Unrealized -6.3%
La Jolla Pharmaceutical Co 8.8%
Value $19.48M Shares 1,064,247 Est. Cost $18.45 Unrealized
Arrowhead Research Corp 7.4%
Value $16.3M Shares 2,410,000 Est. Cost $7.38 Unrealized
Achillion Pharmaceuticals Inc 7.2%
Value $16M Shares 1,622,633 Est. Cost $12.25 Unrealized
bluebird bio Inc 5.5%
Value $12.08M Shares 100,000 Est. Cost $120.77 Unrealized
Targacept Inc 3.6%
Value $7.917M Shares 2,665,643 Est. Cost $2.63 Unrealized
ZS Pharma Inc 1.4%
Value $3.001M Shares 71,315 Est. Cost $41.57 Unrealized
Assembly Biosciences Inc 1.2%
Value $2.701M Shares 204,000 Est. Cost $7.86 Unrealized
Presbia Plc 1.2%
Value $2.587M Shares 350,000 Est. Cost $7.39 Unrealized
Avalanche Biotechnologies In 0.9%
Value $2.079M Shares 51,300 Est. Cost $53.66 Unrealized
Repros Therapeutics Inc 0.9%
Value $1.97M Shares 229,364 Est. Cost $9.97 Unrealized
Coronado Biosciences Inc 0.9%
Value $1.925M Shares 500,000 Est. Cost $3.85 Unrealized
CytRx Corp 0.9%
Value $1.9M Shares 563,814 Est. Cost $2.74 Unrealized
Lipocine Inc 0.7%
Value $1.444M Shares 209,333 Est. Cost $5.26 Unrealized
Taro Pharmaceutical Industries Ltd 0.6%
Value $1.23M Shares 8,721 Est. Cost $148.19 Unrealized
Relypsa Inc 0.5%
Value $1.15M Shares 31,872 Est. Cost $30.80 Unrealized
Lpath Inc 0.1%
Value $148K Shares 60,000 Est. Cost $2.82 Unrealized
SHAK Shake Shack Inc 0.0%
Value $25,000 Shares 500 Est. Cost $44.88 Unrealized 0.0%
Tenax Therapeutics Inc 0.0%
Value $8,000 Shares 2,400 Est. Cost $3.33 Unrealized
BRK/B Berkshire Hathaway Inc 0.0%
Value $7,000 Shares 50 Est. Cost $147.14 Unrealized 0.0%